ArticleComputational intelligence and neuroscience2022
Supervised Machine Learning Empowered Multifactorial Genetic Inheritance Disorder Prediction.
Article in Computational intelligence and neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Artificial Intelligence Applications in Medical Devices for Personalized Health Care Solutions: Systematic Review.Journal of medical Internet research · 2026Pooled it
- Artificial intelligence techniques applied to anxiety disorders recognition: a systematic review.Frontiers in digital health · 2025Pooled it
- Enhancing genomic disorder prediction through Feynman Concordance and Interpolated Nearest Centroid techniques.Scientific reports · 2024Article
- Hematologic Cancer Detection Using White Blood Cancerous Cells Empowered with Transfer Learning and Image Processing.Journal of healthcare engineering · 2023Article
- A multi-view convolutional neural network method combining attention mechanism for diagnosing autism spectrum disorder.PloS one · 2023Article
- Breaking barriers: a statistical and machine learning-based hybrid system for predicting dementia.Frontiers in bioengineering and biotechnology · 2023Article
- Article
- Kidney Cancer Prediction Empowered with Blockchain Security Using Transfer Learning.Sensors (Basel, Switzerland) · 2022Article
- Network Meddling Detection Using Machine Learning Empowered with Blockchain Technology.Sensors (Basel, Switzerland) · 2022Article
- A Review on Machine Learning Approaches in Identification of Pediatric Epilepsy.SN computer science · 2022Article
- IoMT-Based Mitochondrial and Multifactorial Genetic Inheritance Disorder Prediction Using Machine Learning.Computational intelligence and neuroscience · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fatal diseases like cancer, dementia, and diabetes are very dangerous. This leads to fear of death if these are not diagnosed at early stages. Computer science uses biomedical studies to diagnose cancer, dementia, and diabetes. With the advancement of machine learning, there are various techniques which are accessible to predict and prognosis these diseases based on different datasets. These datasets varied (image datasets and CSV datasets) around the world. So, there is a need for some machine learning classifiers to predict cancer, dementia, and diabetes in a human. In this paper, we used a multifactorial genetic inheritance disorder dataset to predict cancer, dementia, and diabetes. Several studies used different machine learning classifiers to predict cancer, dementia, and diabetes separately with the help of different types of datasets. So, in this paper, multiclass classification proposed methodology used support vector machine (SVM) and K-nearest neighbor (KNN) machine learning techniques to predict three diseases and compared these techniques based on accuracy. Simulation results have shown that the proposed model of SVM and KNN for prediction of dementia, cancer, and diabetes from multifactorial genetic inheritance disorder achieved 92.8% and 92.5%, 92.8% and 91.2% accuracy during training and testing, respectively. So, it is observed that proposed SVM-based dementia, cancer, and diabetes from multifactorial genetic inheritance disorder prediction (MGIDP) give attractive results as compared with the proposed model of KNN. The application of the proposed model helps to prognosis and prediction of cancer, dementia, and diabetes before time and plays a vital role to minimize the death ratio around the world.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.